RxDoctor Payments Data

Chad Zawitz

Infectious Disease · Chicago, ILNPI 1548384852

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $149,764 of the $193,334 with a category attached, or 77.5%. Gilead accounts for 88.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $82,812 and has fallen 99.9% since, to $53 in 2025. Among infectious disease clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$193,334in general payments, 2019–2025

Across 274 payments — averaging $705.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$172K
  • Viiv Healthcare Company$22K
  • Merck$112
  • Theratechnologies Inc.$56
  • Janssen Scientific Affairs, LLC$50

What the payments were for

  • Consulting fees$13,6107%
  • Speaking & faculty fees$149,76477%
  • Travel & lodging$23,11512%
  • Food & beverage$6,8454%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$193,334 in reported general payments places this provider in the 95th percentile of 368 infectious disease providers in Illinois.

See all infectious disease providers in Illinois

Other infectious disease in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →